Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents

BACKGROUND: The survival benefit of combination antifungal therapy for invasive mucormycosis (IM) in patients with hematologic malignancy (HM) and hematopoietic cell transplant (HCT) is not well defined. METHODS: This multicenter, retrospective study included HM and HCT recipients with proven or pro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Miller, Matthew A, Molina, Kyle C, Gutman, Jonathan A, Scherger, Sias, Lum, Jessica M, Mossad, Sherif B, Burgess, Mary, Cheng, Matthew P, Chuang, Sally T, Jacobs, Samantha E, Melendez, Dante P, Shah, Dimpy P, Zimmer, Andrea, Sohail, M Rizwan, Syed, Sadia, Walker, Randall C, Poeschla, Eric M, Abidi, Maheen Z
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Major Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7863870/
https://ncbi.nlm.nih.gov/pubmed/33575424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa646
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados